For the year ending 2025-12-31, TGTX made $616,287K in revenue. $447,179K in net income. Net profit margin of 72.56%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenue | 616,287 | 329,004 | ||
| Cost of revenue | 100,714 | 38,486 | ||
| Noncash compensation | 16,618 | 11,160 | ||
| Other research and development | 143,597 | 83,131 | ||
| Total research and development | 160,215 | 94,291 | ||
| Noncash compensation | 48,053 | 31,381 | ||
| Other selling, general and administrative | 183,981 | 122,917 | ||
| Total selling, general and administrative | 232,034 | 154,298 | ||
| Total costs and expenses | 492,963 | - | ||
| Operating income | 123,324 | 41,929 | ||
| Interest expense | 26,727 | 24,028 | ||
| Other income | 10,793 | 7,693 | ||
| Total other expense | -15,934 | -16,335 | ||
| Net income before taxes | 107,390 | 25,594 | ||
| Income tax benefit (expense) | -339,789 | 2,211 | ||
| Net income | 447,179 | 23,383 | ||
| Basic EPS | 3.1 | 0.16 | ||
| Diluted EPS | 2.77 | 0.15 | ||
| Basic Average Shares | 144,316,786 | 145,317,418 | ||
| Diluted Average Shares | 161,412,746 | 160,336,051 | ||
TG THERAPEUTICS, INC. (TGTX)
TG THERAPEUTICS, INC. (TGTX)